Hepatocellular carcinoma (HCC) is the 3rd leading cause of cancer deaths globally, and its complex nature makes management challenging. ROCHE, with support from MyHPBS & Malaysian Oncology Society (MOS) is organising a series of forums to foster a multidisciplinary approach to HCC management. The first event is scheduled for 13 December 2025, at Sheraton Hotel Johor, featuring experienced speakers. A key aspect of this multidisciplinary approach involves the role of the Hepatopancreatobiliary (HPB) surgeon, who provides curative options such as liver resection and liver transplantation for eligible patients.